Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2021 (← Previous) (Next →)

Filing Date: Feb 14, 2022

Total Value ($000): $444,697 (100.0% shares, 0.0% debt)

Holdings (10)

BVS BIOVENTUS 39.4%

Value ($000) $175,281 Shares 12,096,702 Est. Cost $14.24 Unrealized -0.2%

MDXG MIMEDX GROUP, INC. 31.8%

Value ($000) $141,195 Shares 23,376,623 Est. Cost $7.34 Unrealized -5.4%

EYPT EYEPOINT PHARMACEUTICALS INC 11.5%

Value ($000) $51,297 Shares 4,190,921 Est. Cost $4.68 Unrealized +187.5%

— VENUS CONCEPT, INC. 6.2%

Value ($000) $27,774 Shares 21,169,457 Est. Cost $2.99 Unrealized —

TELA TELA BIO, INC. 5.5%

Value ($000) $24,400 Shares 1,906,228 Est. Cost $13.07 Unrealized -3.0%

— SONENDO, INC. 2.6%

Value ($000) $11,477 Shares 1,992,526 Est. Cost $5.76 Unrealized —

— REVANCE THERAPEUTICS INC 1.7%

Value ($000) $7,460 Shares 457,085 Est. Cost $31.50 Unrealized —

MNOV MEDICINOVA INC 0.7%

Value ($000) $2,964 Shares 1,105,941 Est. Cost $2.95 Unrealized +13.3%

AXGN AXOGEN INC 0.6%

Value ($000) $2,777 Shares 296,416 Est. Cost $4.01 Unrealized +199.4%

— CATALYST BIOSCIENCES INC 0.0%

Value ($000) $72 Shares 78,622 Est. Cost $7.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
BVS	BIOVENTUS	12,096,702	$175,281	39.4%	$14.24	-0.2%	COM CL A	09075A108
MDXG	MIMEDX GROUP, INC.	23,376,623	$141,195	31.8%	$7.34	-5.4%	COM	602496101
EYPT	EYEPOINT PHARMACEUTICALS INC	4,190,921	$51,297	11.5%	$4.68	+187.5%	COM NEW	30233G209
—	VENUS CONCEPT, INC.	21,169,457	$27,774	6.2%	$2.99	—	COM	92332W105
TELA	TELA BIO, INC.	1,906,228	$24,400	5.5%	$13.07	-3.0%	COM	872381108
—	SONENDO, INC.	1,992,526	$11,477	2.6%	$5.76	—	COM	835431107
—	REVANCE THERAPEUTICS INC	457,085	$7,460	1.7%	$31.50	—	COM	761330109
MNOV	MEDICINOVA INC	1,105,941	$2,964	0.7%	$2.95	+13.3%	COM NEW	58468P206
AXGN	AXOGEN INC	296,416	$2,777	0.6%	$4.01	+199.4%	COM	05463X106
—	CATALYST BIOSCIENCES INC	78,622	$72	0.0%	$7.36	—	COM NEW	14888D208